Abstract : The study aimed to evaluate if the rate of tissue factor pathway inhibitor during pregnancy and following delivery could be a predictive factor for placenta-mediated adverse pregnancy outcomes in high-risk women.
https://hal.umontpellier.fr/hal-01877092
Contributeur : Mélanie Karli <>
Soumis le : mercredi 19 septembre 2018 - 11:55:01 Dernière modification le : mercredi 24 juin 2020 - 16:19:33